프레이저 증후군 시장 : 검사 유형별, 최종사용자별, 지역별

Frasier Syndrome Market is estimated to be valued at USD 164.1 Mn in 2026 and is expected to reach USD 235.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.

Frasier syndrome (FS) is a rare genetic disorder that affects the kidneys and sexual development. It is characterized by the presence of kidney disease, which can progress to end-stage renal disease, and the development of gonadal dysgenesis, leading to the absence of menstrual cycles in females.

Dr. Prader in 1964 coined the term Frasier syndrome. It is caused by mutations in the WT1 gene located on the short arm of chromosome 11. This gene plays a crucial role in the development of the kidneys and gonads during embryogenesis. Mutations in the WT1 gene disrupt normal cellular processes, leading to the characteristic features of Frasier syndrome.

The incidence of Frasier syndrome is estimated to be around 1 in 100,000 live births. It predominantly affects females, although rare cases have been reported in males as well. The diagnosis of Frasier syndrome is based on clinical features, genetic testing, and histopathological examination of kidney tissue.

Market Dynamics:

The market for Frasier syndrome is driven by several factors. Firstly, rising awareness about genetic disorders and the availability of advanced diagnostic techniques have led to an increased diagnosis rate of Frasier syndrome. This has resulted in a growing demand for genetic tests and screenings, driving market growth.

Secondly, the increasing prevalence of Frasier syndrome has also contributed to market expansion. The need for effective renal replacement therapies and long-term management strategies has created a demand for innovative treatment options.

However, the market for Frasier syndrome faces certain restraints as well. Limited awareness among healthcare professionals and the general public about this rare disorder can lead to underdiagnosis and delayed treatment. Moreover, the high cost of genetic testing and specialized treatments poses a challenge for patients and their families.

Despite these challenges, the market for Frasier syndrome presents several opportunities. The development of targeted therapies and personalized medicine approaches holds promise for improved outcomes in patients with Frasier syndrome. Furthermore, collaborations between research institutions, pharmaceutical companies, and advocacy groups can help drive research on better diagnostic tools and treatment modalities.

Key Features of the Study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global Frasier syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Frasier syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Frasier syndrome market

Frasier Syndrome Market Segmentation:

• By Test Type (Revenue, USD Mn, 2021 - 2033)
• Genetic Testing
• Ultrasound Testing
• Others
• By End User (Revenue, USD Mn, 2021 - 2033)
• Hospitals
• Diagnostic Centers
• Research Institutes
• Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Frasier Syndrome Market:
• Thermo Fisher Scientific
• Invitae Corporation
• GE Healthcare
• Koninklijke Philips N.V.
• Mindray Medical
• Siemens
• Canon Medical Systems Corporation
• FUJIFILM Sonosite Inc.
• ESAOTE SPA, SAMSUNGHEALTHCARE
• Empire Genomics Inc.
• BPL Medical Technologies
• Trivitron Healthcare
• Hitachi Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Frasier Syndrome, By Test Type
  • Market Frasier Syndrome, By End User
  • Market Frasier Syndrome, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
    • Rising awareness about genetic disorders
  • Restraints
    • Limited awareness among healthcare professionals
  • Opportunities
    • The development of targeted therapies and personalized medicine approaches
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Frasier Syndrome Market , By Test Type, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Ultrasound Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Frasier Syndrome Market , By End User, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Frasier Syndrome Market , By Region, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2033 (%)
  • Y-o-Y Growth Analysis, For Country 2022-2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Invitae Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mindray Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Invitae Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FUJIFILM Sonosite Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ESAOTE SPA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• SAMSUNGHEALTHCARE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Empire Genomics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BPL Medical Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Trivitron Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hitachi Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us